| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/05/1997 | EP0759741A1 Mucoadhesive emulsions containing cyclodextrin |
| 03/05/1997 | EP0705097B1 Incorporating poly-n-vinyl amide in a transdermal system |
| 03/05/1997 | EP0552151B1 Antimicrobial hydrogels |
| 03/05/1997 | EP0500885B1 Shaped articles as obtained from a thermoplastic starch melt |
| 03/05/1997 | CN1144484A Acidified nitrite as an antimicrobial agent |
| 03/05/1997 | CN1144478A Bilayer preparations |
| 03/05/1997 | CN1144477A Ophthalmic composition with decreased viscosity |
| 03/05/1997 | CN1144476A Ophthalmic composition containing ion sensitive, hydrophilic polymer and inorganic salt in ratio which gives low viscosity |
| 03/05/1997 | CN1144086A Biological skeleton, biological skeleton-membrane medicine-feeding system |
| 03/04/1997 | US5608060 Diagnosis and treatment of cancer; drug delivery to target cells |
| 03/04/1997 | US5608052 Enzyme inhibitors of beta-lactamase |
| 03/04/1997 | US5608046 Conjugated 4'-desmethyl nucleoside analog compounds |
| 03/04/1997 | US5608039 Single chain B3 antibody fusion proteins and their uses |
| 03/04/1997 | US5608038 Highly concentrated immunoglobulin preparation and method for its production |
| 03/04/1997 | US5607968 Topical alkyl-2-O-L-ascorbyl-phosphates |
| 03/04/1997 | US5607924 DNA photocleavage using texaphyrins |
| 03/04/1997 | US5607707 Optically clear products for use in human and animal healthcare |
| 03/04/1997 | US5607695 Process for the manufacture of porous cellulose matrices |
| 03/04/1997 | US5607694 Forming sealant by mixing virus inactivated fibrinogen and thrombin, liposomes with entrapped medicaments deliverable in wound or opening, and calcium; thrombin promotes fibrin clot formation, liposomes release medicaments |
| 03/04/1997 | US5607691 Compositions and methods for enhanced drug delivery |
| 03/04/1997 | US5607690 Diclofenac, hydroxyethyl-pyrroldine or piperidine |
| 03/04/1997 | US5607685 Protracted-release adminstration forms containing clindamycin palmitate |
| 03/04/1997 | US5607683 Polyether, silver ion, halide or thiocyanate ion, photostability |
| 03/04/1997 | US5607677 Glucan drug delivery system and adjuvant |
| 03/04/1997 | US5607671 Beta lactam antibiotics degrading compound |
| 03/04/1997 | US5607662 Pharmaceutical inhalation compositions |
| 03/04/1997 | US5607661 Aggregates of x-ray microparticles for ultrasound imaging |
| 03/04/1997 | US5607622 Hydrous silicate, polyethylene glycol |
| 03/04/1997 | CA1338958C Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
| 03/01/1997 | CA2184145A1 Process for the preparation of medicament formulations with controlled release |
| 02/27/1997 | WO1997007226A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 02/27/1997 | WO1997007139A2 Stabilized chitin derivative compounds |
| 02/27/1997 | WO1997007118A1 Enediyne compounds |
| 02/27/1997 | WO1997006833A1 Hyper comb-branched polymer conjugates |
| 02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006825A1 Hyperbranched polymers |
| 02/27/1997 | WO1997006824A2 Bioconjugates of manganese complexes and their application as catalysts |
| 02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | WO1997006813A1 Mucosal preparation containing physiologically active peptide |
| 02/27/1997 | WO1997006806A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 02/27/1997 | WO1997006798A2 Pharmaceutical formulations |
| 02/27/1997 | WO1997006782A1 Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics |
| 02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1996040259A3 Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
| 02/27/1997 | CA2229799A1 Bioconjugates of manganese complexes and their application as catalysts |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229269A1 Enediyne compounds |
| 02/27/1997 | CA2228036A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 02/27/1997 | CA2226299A1 Hyper comb-branched polymer conjugates |
| 02/27/1997 | CA2202928A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 02/26/1997 | EP0759452A2 Purified polyether polyols, their manufacture and use |
| 02/26/1997 | EP0759303A1 Colon-specific drug release system |
| 02/26/1997 | EP0759296A1 Rapidly disintegrating formulation comprising tramadol or a tramadol salt |
| 02/26/1997 | EP0759081A1 Glucan-binding proteins, and use thereof |
| 02/26/1997 | EP0759036A1 Immunointeractive molecules-i |
| 02/26/1997 | EP0758906A1 Pegylation reagents and compounds formed therewith |
| 02/26/1997 | EP0758905A1 Pharmaceutical compositions comprising hirudin |
| 02/26/1997 | EP0758901A1 Formulations for il-11 |
| 02/26/1997 | EP0758896A1 Topical preparation containing aciclovir |
| 02/26/1997 | EP0758895A1 Dosage forms and method for ameliorating male erectile dysfunction |
| 02/26/1997 | EP0758889A1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 02/26/1997 | EP0758888A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same |
| 02/26/1997 | EP0758843A1 Modified amino acids for drug delivery |
| 02/26/1997 | EP0587819B1 Medetomidine preparations for transdermal administration |
| 02/26/1997 | CN1143949A Method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of complexes |
| 02/26/1997 | CN1143911A Stabilized composition for oral administration of peptides |
| 02/26/1997 | CN1034105C Nasal formulations and process for preparation |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5606045 Oligonucleotide linked to detectably labeled marker component which comprises porphyrin fluorophore moiety linked to two solubilizing polyoxyhydrocarbyl moieties |
| 02/25/1997 | US5606040 Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group |
| 02/25/1997 | US5606017 Antitumor agents |
| 02/25/1997 | US5605976 Reacting with a tertiary alkyl haloacetate in the presence of a base followed by treatment with an acid |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605934 Adding base to medical solution to increase ph, adding carbon dioxide gas, housing in gas permeable container |
| 02/25/1997 | US5605933 Retinoid conjugate compounds and methods for treating of skin aging |
| 02/25/1997 | US5605892 Improving solubility; light stabilization; adminstering to inhibit fibrin formation following eye surgery |
| 02/25/1997 | US5605890 Viricides |
| 02/25/1997 | US5605889 Contains a disintegrant and exhibits no adverse food effect |
| 02/25/1997 | US5605884 Mixture with sodium or potassium chloride, calcium chloride and histidine buffer |
| 02/25/1997 | US5605703 Liposomes encapsulating doxorubicin |
| 02/25/1997 | US5605702 Eva-based transdermal matrix system for the administration of an estrogen and/or a progestogen |
| 02/25/1997 | US5605700 Topical administration of toremifene and its metabolites |
| 02/25/1997 | US5605696 Drug loaded polymeric material and method of manufacture |
| 02/25/1997 | US5605685 Crosslinked n-vinyl lactam hydrogel and one of pyruvic acid, mono- and polycarboxylated hydrocarbons optionally substituted with hydroxy, and an ammonium or alkali metal salt of the preceding compounds |
| 02/25/1997 | US5605684 Topical thalidomide compositions for surface of mucosal wounds, ulcerations, and lesions |
| 02/25/1997 | US5605651 Storage stability; heat resistance; containing alkyl polyglycosides |
| 02/20/1997 | WO1997006202A1 Block polymer having functional groups at both ends |
| 02/20/1997 | WO1997006176A2 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 02/20/1997 | WO1997005903A2 Composition for enhanced uptake of polar drugs from the colon |
| 02/20/1997 | WO1997005901A1 Targeting of organs by immunoconjugates |
| 02/20/1997 | WO1997005891A1 Use of plasminogene activators to stimulate local bone growth |
| 02/20/1997 | WO1997005881A1 Stable solid formulation of enalapril salt and process for preparation thereof |
| 02/20/1997 | WO1997005880A1 Aqueous compositions containing ciprofloxacine, and related use and process |
| 02/20/1997 | WO1997005860A1 Photostable aqueous solution containing benzyl alcohol derivatives |
| 02/20/1997 | WO1997002810A3 Polymeric lamellar substrate particles for drug delivery |
| 02/20/1997 | WO1997000638A3 Apparatus and method for making gas-filled vesicles of optimal size |
| 02/20/1997 | WO1996040260A3 Immunotoxins specific for cd80 and cd86 expressing cells |
| 02/20/1997 | WO1996038571A3 Recombinant polypeptide cytotoxins for cancer treatment |
| 02/20/1997 | DE19530884A1 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Infektionen Use of prostane derivatives and their combination with antibiotics to treat bacterial infections |